By: Andrew Yakubovich
A recent article published by the Wall Street Journal discusses a scenario far too common for people dealing with cancer – extremely high costs of treatment. The author, Peter Loftus, explains that NextSource Biotechnology has pulled out of a federal discount program for Medicare patients, resulting in a lack of coverage for…
